This segment conveys the importance of decentralizing clinical trials to increase diversity and serve all types of people in the United States, as well as the industry. In addition, it touches on the importance of having diverse investigators to help recruit and communicate with all types of people.
Pricing Climate Impacting Commercial Considerations
May 3rd 2024In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.
Q&A with Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk
October 25th 2023Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, shares her insights on fostering collaboration, embracing change, and her compelling vision to revolutionize digital transformation and innovation in the field of healthcare.